CVS stops sale of heartburn drugs with suspect contaminant
CVS has halted sales of popular heartburn treatment Zantac and the store generic version after warnings by U.S. health regulators.
CVS is the latest retailer to pull the heartburn tablets from store shelves. Earlier this month, the U.S. Food and Drug Administration warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac. The agency said it had detected a “probable†cancer-causing chemical in the medications, which are sold as both prescription and over-the-counter treatments to treat stomach acid and ulcers.
In its announcement this weekend, CVS said customers who bought Zantac products could return them for a refund. The retailer will continue to sell other heartburn medications, such as Pepcid.
Some manufacturers of the drug have stopped distribution. Health officials say concerned patients should consult their doctor.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
